INFUSE BONE GRAFT 7510200

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a 03,05 report with the FDA on 2015-02-18 for INFUSE BONE GRAFT 7510200 manufactured by Medtronic Sofamor Danek Usa, Inc.

Event Text Entries

[5411057] It was reported in a publication that the patient presented wearing an upper complete denture, seeking dental treatment for oral rehabilitation through osseointegrated implants. The patient reported an aesthetical complaint because of the increase of facial wrinkles and masticatory and phonetic difficulty due to the instability provided by the complete denture. At clinical examination, the complete absence of the upper teeth and the partial loss of the lower teeth were observed. At the preoperatively imaging examination, the computed tomography revealed the severe atrophy of the anterior area of the maxilla, at both horizontal and vertical directions. Moreover, there was a bilateral maxillary sinus pneumatization. The patient underwent reconstruction of the maxilla using synthetic bone substitute (bone ceramic 500-1000 micrometers, straumann, basel, suisse), two 1. 5 mm profile titanium plates of 1. 5 (osteosin, (b)(4)) fixed at both sides of the anterior region of maxilla with 5 mm? 1. 5 mm screws (osteosin, (b)(4)), and rhbmp-2/acs combined (infuse bone graft, 3. 2ml) prepared according to the manufacturer's recommendations and placed below the titanium plates. Post-operative medication comprised amoxicillin 875 mg + potassium clavulanate 125 mg every 12 h; paracetamol, 750 mg, every 6 h; di clofenac sodium, 50 mg, every 24 h; and 0. 12% chlorhexidine digluconate every 12 h. Trans- and post-operative period was uneventful without pain, but with edema. After 30 days, the denture was rebased with soft liner material. Eight months after rhbmp-2 surgery was planned installation of implants. After 6 months, fixed prosthesison implants was installed. Clinical and imaging examinations were performed during the post-operative period, the smile analysis not been taken. After 2 years and 5 months of following-up, a satisfactory functional and aesthetical rehabilitation was achieved.
Patient Sequence No: 1, Text Type: D, B5


[12929315] Literature citation: z? Tola et al. Recombinant human bone morphogenetic protein type 2 in the reconstruction of atrophic maxilla: case report with long-term follow-up. Journal of indian society of periodontology. 2014 nov-dec; 18(6): 781? 785. Implanted date: (b)(6) 2008. (b)(6). (b)(4). Neither the device nor films of applicable imaging studies were returned to the manufacturer for evaluation. Therefore, we are unable to determine the definitive cause of the reported event. Products from multiple manufacturers were implanted during the procedure. Although it is unknown if any of the devices contributed to the reported event, we are filing this mdr for notification purposes.
Patient Sequence No: 1, Text Type: N, H10


MAUDE Entry Details

Report Number1030489-2015-00328
MDR Report Key4524293
Report Source03,05
Date Received2015-02-18
Date of Report2015-01-31
Date of Event2014-11-01
Date Mfgr Received2015-01-31
Date Added to Maude2015-02-18
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Health Professional3
Initial Report to FDA3
Report to FDA0
Event Location0
Manufacturer ContactHUZEFA MAMOOLA
Manufacturer Street1800 PYRAMID PLACE
Manufacturer CityMEMPHIS TN 38132
Manufacturer CountryUS
Manufacturer Postal38132
Manufacturer Phone9013963133
Manufacturer G1MEDTRONIC SOFAMOR DANEK
Manufacturer Street1800 PYRAMID PLACE
Manufacturer CityMEMPHIS TN 38132
Manufacturer CountryUS
Manufacturer Postal Code38132
Single Use3
Previous Use Code3
Event Type3
Type of Report3

Device Details

Brand NameINFUSE BONE GRAFT
Generic NameBONE GRAFTING MATERIAL, DENTAL, WITH BIOLOGIC COMPONENT
Product CodeNPZ
Date Received2015-02-18
Model NumberNA
Catalog Number7510200
Lot NumberUNK
ID NumberNA
OperatorHEALTH PROFESSIONAL
Device AvailabilityN
Device Eval'ed by MfgrN
Device Sequence No1
Device Event Key0
ManufacturerMEDTRONIC SOFAMOR DANEK USA, INC
Manufacturer Address4340 SWINEA RD MEMPHIS TN 38118 US 38118


Patients

Patient NumberTreatmentOutcomeDate
101. Other 2015-02-18

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.